Zevra Therapeutics, Inc. (ZVRA)
NASDAQ: ZVRA · IEX Real-Time Price · USD
5.85
-0.26 (-4.26%)
At close: Jul 12, 2024, 4:00 PM
5.76
-0.09 (-1.54%)
After-hours: Jul 12, 2024, 7:46 PM EDT

Zevra Therapeutics Stock Forecast

Stock Price Forecast

The 3 analysts with 12-month price forecasts for Zevra Therapeutics stock have an average target of 20, with a low estimate of 15 and a high estimate of 25. The average target predicts an increase of 241.88% from the current stock price of 5.85.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $15 $20 $20 $25
Change +156.41% +241.88% +241.88% +327.35%

Analyst Ratings

The average analyst rating for ZVRA stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Feb '24Mar '24Apr '24May '24Jun '24Jul '24
Strong Buy 443333
Buy 012222
Hold 000000
Sell 000000
Strong Sell 000000
Total 455555

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$15
Strong Buy Reiterates $15 +156.41% Jul 9, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$15
Strong Buy Reiterates $15 +156.41% Apr 3, 2024
Cantor Fitzgerald
Cantor Fitzgerald
Buy
Reiterates
n/a
Buy Reiterates n/a n/a Apr 1, 2024
William Blair
William Blair
Buy
Initiates
n/a
Buy Initiates n/a n/a Mar 12, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$15
Strong Buy Reiterates $15 +156.41% Mar 5, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
29.45M
from 27.46M
Increased by 7.22%
Revenue Next Year
85.03M
from 29.45M
Increased by 188.76%
EPS This Year
-1.64
from -1.30
EPS Next Year
-0.60
from -1.64
Year 2019202020212022202320242025202620272028
Revenue
12.84M13.29M28.65M10.16M27.46M29.45M85.03M148.67M234.94M292.85M
Revenue Growth
-3.50%115.61%-64.53%170.26%7.22%188.76%74.85%58.03%24.65%
EPS
-13.23-3.21-2.11-0.78-1.30-1.64-0.600.341.862.60
EPS Growth
--------448.95%39.78%
Forward PE
-------17.273.152.25
No. Analysts -----88866
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20242025202620272028
High 39.8M 103.9M 179.6M 283.1M 328.2M
Avg 29.4M 85.0M 148.7M 234.9M 292.9M
Low 22.7M 66.5M 110.4M 192.1M 232.9M

Revenue Growth

Revenue Growth 20242025202620272028
High
44.9%
252.7%
111.2%
90.4%
39.7%
Avg
7.2%
188.8%
74.9%
58.0%
24.6%
Low
-17.5%
125.8%
29.8%
29.2%
-0.9%

EPS Forecast

EPS 20242025202620272028
High -1.40 -0.26 0.98 2.77 3.16
Avg -1.64 -0.60 0.34 1.86 2.60
Low -1.76 -1.10 -0.52 1.16 2.04

EPS Growth

EPS Growth 20242025202620272028
High - - -
718.6%
70.0%
Avg - - -
448.9%
39.8%
Low - - -
241.5%
9.7%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.